The Canterbury startup is signing up customers for its pharmacy management platform but faces an incumbent player with a market stranglehold.
Forsyth Barr analyst sets target stock price at 56% above current level.
But the sector is under-performing on exports compared to global potential.
Resignation comes just a month after AGM confirming her board appointment.
A security provider finds most Kiwi businesses could be fooled by similar email tricks.
Callaghan's Simon Yarrow says NZ needs to harness a rising tide of foreign investment.
Technology: The radio spectrum allocated to two major telcos tells a revealing tale.
Overseas figures show how quickly second wave could reverse gains.
Share price fell 5% after the Huljich family sold 14.4 million shares.
As tech becomes more complex, one expert says spotting investment bubbles will get harder.